Teladoc Health, Inc.
TDOC
$7.59
$0.141.88%
NYSE
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 2.53B | 2.54B | 2.55B | 2.57B | 2.59B |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 2.53B | 2.54B | 2.55B | 2.57B | 2.59B |
| Cost of Revenue | 763.47M | 756.04M | 753.56M | 751.27M | 755.77M |
| Gross Profit | 1.76B | 1.79B | 1.80B | 1.82B | 1.83B |
| SG&A Expenses | 1.30B | 1.32B | 1.33B | 1.35B | 1.33B |
| Depreciation & Amortization | 358.76M | 359.96M | 363.53M | 373.55M | 381.55M |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 2.71B | 2.73B | 2.74B | 2.78B | 2.79B |
| Operating Income | -178.59M | -183.49M | -186.65M | -208.79M | -196.55M |
| Income Before Tax | -250.08M | -232.36M | -1.03B | -993.65M | -970.86M |
| Income Tax Expenses | -26.50M | -25.00M | -13.35M | 7.59M | 10.87M |
| Earnings from Continuing Operations | -223.59 | -207.36 | -1.01K | -1.00K | -981.73 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -223.59M | -207.36M | -1.01B | -1.00B | -981.73M |
| EBIT | -178.59M | -183.49M | -186.65M | -208.79M | -196.55M |
| EBITDA | 16.17M | 18.88M | 32.82M | 31.72M | 63.58M |
| EPS Basic | -1.28 | -1.19 | -5.93 | -5.88 | -5.78 |
| Normalized Basic EPS | -0.55 | -0.53 | -0.57 | -0.67 | -0.58 |
| EPS Diluted | -1.28 | -1.19 | -5.93 | -5.88 | -5.78 |
| Normalized Diluted EPS | -0.55 | -0.53 | -0.57 | -0.67 | -0.58 |
| Average Basic Shares Outstanding | 699.77M | 694.33M | 688.65M | 682.22M | 675.52M |
| Average Diluted Shares Outstanding | 699.77M | 694.33M | 688.65M | 682.22M | 675.52M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |